Abstract |
Human ehrlichiosis is an emerging pathogen in immunocompromised patients, potentially leading to increased morbidity compared to immunocompetent patients. A high index of suspicion is imperative and early treatment with doxycycline can be life-saving. We report the case of an immunosuppressed renal transplant patient who was diagnosed with human monocytic ehrlichiosis and successfully treated with doxycycline.
|
Authors | Casey Cotant, Jason F Okulicz, Barton Brezina, Daniel J Riley, Nicholas G Conger |
Journal | Scandinavian journal of infectious diseases
(Scand J Infect Dis)
Vol. 38
Issue 8
Pg. 699-702
( 2006)
ISSN: 0036-5548 [Print] England |
PMID | 16857619
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
|
Topics |
- Doxycycline
(therapeutic use)
- Ehrlichiosis
(drug therapy, immunology)
- Humans
- Immunosuppression Therapy
(adverse effects)
- Kidney Transplantation
(immunology)
- Male
- Middle Aged
|